That it would even be enough to start a small US imitation Omega Seamaster collection watches and have enough variation replica rolex in color as to not be redundant.

In de wereld van verzamelen en op het internet horloges replica der dingen gebeurt alles in deze nichehoeken, zoals forums, YouTube-kanalen en blogs.

Search

FDA no longer needs to require animal tests before human drug trials, We are an international end user assessed ethically compliant and technically competent HBS provider through Science Exchange platform

Latest Events

Transcell’s Transtoxbio & Wipro HOLMES™

Transcell’s Transtoxbio & Wipro HOLMES™ Cooperation – Towards Human Relevant Science Based Next Gen Testing Platforms Disrupting Methodologies In Safety & Efficacy Validations

CRC Pharma conducted international workshop on Translational Research Strategies for Drug Discovery and Clinical Development. July 2019, Hyderabad

AAPM Meeting. Nov 8th 2019, San Jose

Transtox products CEO S Dravida has presented on “Stem Cell Based Platforms As Alternative Models – Use Cases In Drug Discovery, Development, Exploratory And Regulatory Toxicity Testing’s” in International workshop on “Translational Research Strategies for Drug Discovery and Clinical Development”

Transtox products CEO S Dravida has presented on “Stem Cell Based Platforms As Alternative Models – Use Cases In Drug Discovery, Development, Exploratory And Regulatory Toxicity Testing’s” in International workshop on “Translational Research Strategies for Drug Discovery and Clinical Development” that was conducted on 20th and 21st July 2019 at Hyderabad, India., Organized in collaboration withPharmaceuticals Export Promotion Council of India (Pharmexcil) and American Association of Precision Medicine (AAPM), USA.

The presentation covered:

  • Human sourced primary progenitor cellular platforms as invitro and meaningful predictive real time products for high throughput screening of chemical libraries
  • Identification of hits and lead optimization
  • Certain independent tests like: Mutagenicity, Tumorogenicity, Cytotoxicity, LD50, Molecular targets, Protein target identification and Drug repurposing
  • Certain complementary tests like: ADME, hepatotoxicity and cardiotoxicity
  • Highlighted the integration/adoption of right kind of pre-clinical models that are not traditional, but are modern and 100% close to human physiology, till regulatory testing’s for better prognosis of drug candidates in clinics
Transtoxbio representation in the 6th webinar conducted by CPHMS (Centre for Predictive Human Model Systems), Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC – CCMB) on 
23rd Jan 2021.
 
Primary Stem Cell/Tissue Based Platforms As Human Surrogate Systems – Compelling Alternatives – Pluripotent Imagination Of The User 
Presented on Nov 19th 2020 at the First International Conference series on 3R’s Research & Progress; Conducted by School of Life Sciences, University of Hyderabad and Oncoseek Bio 
Back to Top
Product has been added to your cart